Olon S.p.A., an active pharmaceutical ingredients (API) contract development and manufacturing organization (CDMO) and generics supplier, has started the construction of a new GMP manufacturing facility at its microbial CDMO facility located in Capua, Italy.
 
“I am pleased to announce the start of this GMP capacity expansion just within 6 months after the acquisition of Capua BioServices,” said Paolo Tubertini, chief executive officer, Olon. “This truly confirms the real opportunity to accelerate growth in Olon’s CDMO service positioning and to be recognized as European Leader in the CDMO of microbial fermentation.”
 
The construction of this new GMP facility is associated to a long-term strategic partnership with a large pharmaceutical company. The engineering project is designed to support the manufacture of multiple products, up to commercial scale. It is a great addition to Olon’s recent successes in the development and execution of GMP as well as food-grade engineering projects; from first concept to final commissioning, based on green-field and brown-field, under extremely challenged timelines.